myocardial ischemia reperfusion injury
Conditions
Interventions
control group:placebo
Treatment group:Yixin Decoction
Sponsors
Shuguang Hospital affiliated with Shanghai University of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: ?Age 18-80 years old, gender is not limited ?Patients with acute myocardial infarction who can undergo PCI ?Patients with Qi deficiency and blood stasis who meet the TCM differentiation; ?Volunteer to be tested and sign informed consent ? Those who have not received Yixin Prescription treatment before
Exclusion criteria
Exclusion criteria: (1) Patients with severe pulmonary insufficiency; (2) Patients with serious primary diseases such as heart, liver, brain, kidney and hematopoietic system, and psychosis; (3) There is controversy over the differentiation of TCM classification; (4) Women who are pregnant or planning to become pregnant or lactating; (5) Those who are known to be allergic to such drugs and have severe allergies; (6) Patients who have participated in other clinical drug trials in the past 3 months; (7) Unable or unwilling to sign informed consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy of TCM symptoms; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical endpoint events;Cardiac enzymes;Cardiac troponin I;electrocardiogram;Plasma type B brain natriuretic peptide;Amino-terminal brain natriuretic peptide precursor;superoxide dismutase;IL-6;IL-1;TNF-a; | — |
Countries
China
Contacts
Public ContactRong Jingfeng
Shuguang Hospital affiliated with Shanghai University of TCM
Outcome results
None listed